Valuation: Uscom Limited

Market Cap 3.12M 2.2M 1.91M 1.78M 1.63M 3.07M 210M 20.9M 8.2M 105M 8.28M 8.1M 348M P/E 2024
-1.25x
P/E 2025 -0.88x
Enterprise Value 4.42M 3.12M 2.7M 2.52M 2.31M 4.35M 297M 29.58M 11.61M 149M 11.72M 11.46M 492M EV / Sales 2024
0.57x
EV / Sales 2025 2.06x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
1 year 0.01
Extreme 0.011
0.01
3 years 0.01
Extreme 0.011
0.05
5 years 0.01
Extreme 0.011
0.16
10 years 0.01
Extreme 0.011
0.53
Manager TitleAgeSince
Chief Executive Officer - 06/03/2011
Corporate Secretary 66 23/05/2016
Corporate Officer/Principal - 27/05/2018
Director TitleAgeSince
Chairman - 31/10/2009
Director/Board Member 66 22/08/2018
Director/Board Member 62 15/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+9.09%-.--%+9.09%-76.00% 2.2M
+2.41%+3.43%+28.93%+6.88% 220B
+2.39%+5.02%+2.09%-20.96% 144B
+1.36%+7.21%-19.42%+25.07% 134B
+0.02%+5.52%-52.19%-2.51% 71.46B
+0.45%+4.24%+14.51%+14.16% 51.71B
+1.05%+7.19%-14.90%-17.93% 50.84B
+3.28%+5.49%+27.35%+13.73% 41.23B
+1.79%+7.83%+44.69%+37.11% 39.95B
+2.08%+5.51%-0.32%-2.92% 32.42B
Average +2.39%+5.00%+3.98%-2.34% 78.5B
Weighted average by Cap. +1.79%+5.17%+4.10%+4.39%

Financials

2024 2025
Net sales 3.73M 2.63M 2.28M 2.13M 1.95M 3.67M 251M 24.95M 9.79M 126M 9.88M 9.67M 415M 2.58M 1.82M 1.58M 1.47M 1.35M 2.54M 173M 17.26M 6.77M 86.88M 6.84M 6.69M 287M
Net income -2.07M -1.47M -1.27M -1.18M -1.09M -2.04M -139M -13.89M -5.45M -69.9M -5.5M -5.38M -231M -3.3M -2.33M -2.02M -1.88M -1.73M -3.25M -222M -22.11M -8.68M -111M -8.76M -8.57M -368M
Net Debt -1.53M -1.08M -935K -873K -801K -1.51M -103M -10.25M -4.02M -51.57M -4.06M -3.97M -170M 1.3M 916K 792K 740K 679K 1.28M 87.19M 8.68M 3.41M 43.7M 3.44M 3.36M 144M
Logo Uscom Limited
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Employees
35